The Rotterdam Scan Study: design update 2016 and main findings

European Journal of Epidemiology

Volumn 30, Issue 12, 2015, Pages 1299-1315

  Ikram, M Arfan ^a   van der Lugt, Aad ^a   Niessen, Wiro J ^a,b   Koudstaal, Peter J ^a   Krestin, Gabriel P ^a   Hofman, Albert ^a   Bos, Daniel ^a   Vernooij, Meike W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Alzheimer s disease; Cerebral blood flow; Cohort study; Dementia; Diffusion tensor imaging; Epidemiology; Genetics; Infarcts; Microbleeds; Neuroimaging; Population based; Risk factors; Stroke; White matter lesions

Indexed keywords

ARTICLE; BRAIN BLOOD FLOW; BRAIN TISSUE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONNECTOME; DIFFUSION TENSOR IMAGING; DISEASE CLASSIFICATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETICS; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; INCIDENTAL FINDING; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; RESTING STATE NETWORK; STRUCTURE ANALYSIS; WHITE MATTER; WHITE MATTER LESION; AGED; AGING; BRAIN; BRAIN ARTERY; BRAIN MAPPING; CHRONIC DISEASE; COMPUTER ASSISTED DIAGNOSIS; FEMALE; HEALTH SURVEY; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NETHERLANDS; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; BRAIN; BRAIN MAPPING; CEREBRAL ARTERIES; CHRONIC DISEASE; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NETHERLANDS; NEUROIMAGING; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84952639596     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-015-0105-7     Document Type: Article

References (152)

1. Hachinski V. Stroke and Alzheimer disease: fellow travelers or partners in crime? Arch Neurol. 2011;68(6):797–8.
2. Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R, et al. Lifetime risk of dementia and Alzheimer’s disease. The impact of mortality on risk estimates in the Framingham Study. Neurology. 1997;49(6):1498–504.
3. Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol. 2007;6(12):1106–14.
4. Thies W, Bleiler L. 2011 Alzheimer’s disease facts and figures. Alzheimers Dement. 2011;7(2):208–44.
5. Meyer JS, Kawamura J, Terayama Y. White matter lesions in the elderly. J Neurol Sci. 1992;110(1–2):1–7.
6. Pantoni L, Leys D, Fazekas F, Longstreth WT Jr, Inzitari D, Wallin A, et al. Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis Assoc Disord. 1999;13(Suppl 3):S49–54.
7. Fazekas F, Niederkorn K, Schmidt R, Offenbacher H, Horner S, Bertha G, et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke. 1988;19(10):1285–8.
8. Hachinski VC. The decline and resurgence of vascular dementia. CMAJ. 1990;142(2):107–11.
9. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43(9):1683–9.
10. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28(3):652–9.
11. DeCarli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, et al. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging. 2005;26(4):491–510.
12. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology. 2001;56(11):1539–45.
13. Launer LJ, Oudkerk M, Nilsson LG, Alperovitch A, Berger K, Breteler MM, et al. CASCADE: a European collaborative study on vascular determinants of brain lesions. Study design and objectives. Neuroepidemiology. 2000;19(3):113–20.
14. Launer LJ. Epidemiology of white-matter lesions. Int Psychogeriatr. 2003;15(Suppl 1):99–103.
15. Launer LJ. Epidemiology of white matter lesions. Top Magn Reson Imaging. 2004;15(6):365–7.
16. Massaro JM, D’Agostino RB Sr, Sullivan LM, Beiser A, DeCarli C, Au R, et al. Managing and analysing data from a large-scale study on Framingham Offspring relating brain structure to cognitive function. Stat Med. 2004;23(2):351–67.
17. Schmidt R, Fazekas F, Offenbacher H, Lytwyn H, Blematl B, Niederkorn K, et al. Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol. 1991;48(4):417–20.
18. Schmidt R, Fazekas F, Kapeller P, Schmidt H, Hartung HP. MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology. 1999;53(1):132–9.
19. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001;70(1):9–14.
20. Ikram MA, van der Lugt A, Niessen WJ, Krestin GP, Koudstaal PJ, Hofman A, et al. The Rotterdam Scan Study: design and update up to 2012. Eur J Epidemiol. 2011;26(10):811–24.
21. Hofman A, Brusselle GG, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, et al. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol. 2015;30(8):661–708.
22. Jones DK, Simmons A, Williams SC, Horsfield MA. Non-invasive assessment of axonal fiber connectivity in the human brain via diffusion tensor MRI. Magn Reson Med. 1999;42(1):37–41.
23. Jones DK, Horsfield MA, Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med. 1999;42(3):515–25.
24. Buijs PC, Krabbe-Hartkamp MJ, Bakker CJ, de Lange EE, Ramos LM, Breteler MM, et al. Effect of age on cerebral blood flow: measurement with ungated two-dimensional phase-contrast MR angiography in 250 adults. Radiology. 1998;209(3):667–74.
25. Klein S, Staring M, Pluim JP. Comparison of gradient approximation techniques for optimisation of mutual information in nonrigid registration. Proceedings of the SPIE medical imaging: image process; 2005
26. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998;17(1):87–97.
27. Anbeek P, Vincken KL, van Bochove GS, van Osch MJ, van der Grond J. Probabilistic segmentation of brain tissue in MR imaging. Neuroimage. 2005;27(4):795–804.
28. Blatter DD, Bigler ED, Gale SD, Johnson SC, Anderson CV, Burnett BM, et al. Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. AJNR Am J Neuroradiol. 1995;16(2):241–51.
29. Cardenas VA, Ezekiel F, Di Sclafani V, Gomberg B, Fein G. Reliability of tissue volumes and their spatial distribution for segmented magnetic resonance images. Psychiatry Res. 2001;106(3):193–205.
30. Jernigan TL, Gamst AC. Changes in volume with age–consistency and interpretation of observed effects. Neurobiol Aging. 2005;26(9):1271–4; discussion 5-8.
31. Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci. 2003;23(8):3295–301.
32. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. Mapping cortical change across the human life span. Nat Neurosci. 2003;6(3):309–15.
33. Vrooman HA, Cocosco CA, van der Lijn F, Stokking R, Ikram MA, Vernooij MW, et al. Multi-spectral brain tissue segmentation using automatically trained k-Nearest-Neighbor classification. Neuroimage. 2007;37(1):71–81.
34. de Boer R, Vrooman HA, Ikram MA, Vernooij MW, Breteler MM, van der Lugt A, et al. Accuracy and reproducibility study of automatic MRI brain tissue segmentation methods. Neuroimage. 2010;51(3):1047–56.
35. Bokde AL, Teipel SJ, Schwarz R, Leinsinger G, Buerger K, Moeller T, et al. Reliable manual segmentation of the frontal, parietal, temporal, and occipital lobes on magnetic resonance images of healthy subjects. Brain Res Brain Res Protoc. 2005;14(3):135–45.
36. Bokde AL, Teipel SJ, Zebuhr Y, Leinsinger G, Gootjes L, Schwarz R, et al. A new rapid landmark-based regional MRI segmentation method of the brain. J Neurol Sci. 2002;194(1):35–40.
37. Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MM. Kidney function is related to cerebral small vessel disease. Stroke. 2008;39(1):55–61.
38. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA. 2000;97(20):11050–5.
39. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. 1999;9(2):179–94.
40. de Boer R, Vrooman HA, van der Lijn F, Vernooij MW, Ikram MA, van der Lugt A, et al. White matter lesion extension to automatic brain tissue segmentation on MRI. Neuroimage. 2009;45(4):1151–61.
41. Verhaaren BF, de Boer R, Vernooij MW, Rivadeneira F, Uitterlinden AG, Hofman A, et al. Replication study of chr17q25 with cerebral white matter lesion volume. Stroke. 2011;42(11):3297–9.
42. Boykov Y, Veksler O, Zabih R. Fast approximate energy minimization via graph cuts. IEEE Trans Patt Anal Mach Intell. 2001;23(11):1222–39.
43. van der Lijn F, den Heijer T, Breteler MM, Niessen WJ. Hippocampus segmentation in MR images using atlas registration, voxel classification, and graph cuts. Neuroimage. 2008;43(4):708–20.
44. den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, Breteler MM. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology. 2002;59(5):746–8.
45. den Heijer T, Tiemeier H, Luijendijk HJ, van der Lijn F, Koudstaal PJ, Hofman A, et al. A study of the bidirectional association between hippocampal volume on magnetic resonance imaging and depression in the elderly. Biol Psychiatry. 2011;70(2):191–7.
46. den Heijer T, van der Lijn F, Koudstaal PJ, Hofman A, van der Lugt A, Krestin GP, et al. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain. 2010;133(Pt 4):1163–72.
47. van der Lijn F, de Bruijne M, Klein S, den Heijer T, Hoogendam YY, van der Lugt A, et al. Automated brain structure segmentation based on atlas registration and appearance models. IEEE Trans Med Imaging. 2012;31(2):276–86.
48. van der Lijn F, Vernooij MW, Ikram MA, Vrooman H, Rueckert D, Hammers A et al. Automated localization of periventricular and subcortical white matter lesions. Progress in biomedical optics and imaging—SPIE; 2007.
49. van der Lijn F, de Bruijne M, Hoogendam YY, Klein S, Hameeteman R, Breteler MM et al. Cerebellum segmentation in MRI using atlas registration and local multi-scale image descriptors. Proceedings—2009 IEEE international symposium on biomedical imaging: from Nano to Macro; 2009.
50. Hoogendam YY, van der Geest JN, van der Lijn F, van der Lugt A, Niessen WJ, Krestin GP, et al. Determinants of cerebellar and cerebral volume in the general elderly population. Neurobiol Aging. 2012;33(12):2774–81.
51. Achterberg HC, van der Lijn F, den Heijer T, van der Lugt A, Breteler MM, Niessen WJ et al. Prediction of dementia by hippocampal shape analysis. Lecture Notes in Computer Sciences including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics. 2010. p 42–9.
52. Vernooij MW, Ikram MA, Vrooman HA, Wielopolski PA, Krestin GP, Hofman A, et al. White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry. 2009;66(5):545–53.
53. Vernooij MW, de Groot M, van der Lugt A, Ikram MA, Krestin GP, Hofman A, et al. White matter atrophy and lesion formation explain the loss of structural integrity of white matter in aging. Neuroimage. 2008;43(3):470–7.
54. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23(Suppl 1):S208–19.
55. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006;31(4):1487–505.
56. Klein S, Staring M, Murphy K, Viergever MA, Pluim JP. elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging. 2010;29(1):196–205.
57. Andersson JLR, Jenkinson M, Smith SM. Non-linear registration, aka spatial normalisation. FMRIB technical report TR07JA22010.
58. de Groot M, Vernooij MW, Klein S, Ikram MA, Vos FM, Smith SM, et al. Improving alignment in Tract-based spatial statistics: evaluation and optimization of image registration. Neuroimage. 2013;76:400–11.
59. de Boer R, Schaap M, van der Lijn F, Vrooman HA, de Groot M, van der Lugt A, et al. Statistical analysis of minimum cost path based structural brain connectivity. Neuroimage. 2011;55(2):557–65.
60. de Boer R, Schaap M, van der Lijn F, Vrooman HA, de Groot M, Vernooij MW, et al. Statistical analysis of structural brain connectivity. Med Image Comput Comput Assist Interv. 2010;13(Pt 2):101–8.
61. Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, Salat DH, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex. 2004;14(1):11–22.
62. Fischl B, Salat DH, van der Kouwe AJ, Makris N, Segonne F, Quinn BT, et al. Sequence-independent segmentation of magnetic resonance images. Neuroimage. 2004;23(Suppl 1):S69–84.
63. Beckmann CF, Smith SM. Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans Med Imaging. 2004;23(2):137–52.
64. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17(2):825–41.
65. Griffanti L, Salimi-Khorshidi G, Beckmann CF, Auerbach EJ, Douaud G, Sexton CE, et al. ICA-based artefact removal and accelerated fMRI acquisition for improved resting state network imaging. Neuroimage. 2014;95:232–47.
66. Salimi-Khorshidi G, Douaud G, Beckmann CF, Glasser MF, Griffanti L, Smith SM. Automatic denoising of functional MRI data: combining independent component analysis and hierarchical fusion of classifiers. Neuroimage. 2014;90:449–68.
67. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci USA. 2009;106(17):7209–14.
68. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18):1821–8.
69. Vernooij MW, Ikram MA, Hofman A, Krestin GP, Breteler MM, van der Lugt A. Superficial siderosis in the general population. Neurology. 2009;73(3):202–5.
70. Riba-Llena I, Koek M, Verhaaren BF, Vrooman HA, van der Lugt A, Hofman A, et al. Small cortical infarcts: prevalence, determinants, and cognitive correlates in the general population. Int J Stroke. 2015;. doi:10.1111/ijs.12543.
71. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8(2):165–74.
72. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70(14):1208–14.
73. Adams HH, Cavalieri M, Verhaaren BF, Bos D, van der Lugt A, Enzinger C, et al. Rating method for dilated Virchow-Robin spaces on magnetic resonance imaging. Stroke. 2013;44(6):1732–5.
74. Adams HH, Hilal S, Schwingenschuh P, Wittfeld K, Van der Lee SJ, Decarli C et al. A Priori Collaboration in Population Imaging: the Uniform Neuro-Imaging of Virchow-Robin Spaces Enlargement (UNIVRSE) Consortium. Alzheimers Dement: Diagnosis, Assessment & Disease; 2015. doi:10.1016/j.dadm.2015.10.004.
75. de Jong FJ, Vernooij MW, Ikram MK, Ikram MA, Hofman A, Krestin GP, et al. Arteriolar oxygen saturation, cerebral blood flow, and retinal vessel diameters. The Rotterdam Study. Ophthalmology. 2008;115(5):887–92.
76. Ikram MA, van Oijen M, de Jong FJ, Kors JA, Koudstaal PJ, Hofman A, et al. Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease. Stroke. 2008;39(5):1421–6.
77. Ikram MA, Vrooman HA, Vernooij MW, van der Lijn F, Hofman A, van der Lugt A, et al. Brain tissue volumes in the general elderly population. The Rotterdam Scan Study. Neurobiol Aging. 2008;29(6):882–90.
78. Ikram MK, De Jong FJ, Van Dijk EJ, Prins ND, Hofman A, Breteler MM, et al. Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study. Brain. 2006;129(Pt 1):182–8.
79. Ikram MK, Sim X, Jensen RA, Cotch MF, Hewitt AW, Ikram MA, et al. Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genet. 2010;6(10):e1001184.
80. van Dijk EJ, Breteler MM, Schmidt R, Berger K, Nilsson LG, Oudkerk M, et al. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension. 2004;44(5):625–30.
81. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation. 2005;112(6):900–5.
82. Verhaaren BF, Vernooij MW, de Boer R, Hofman A, Niessen WJ, van der Lugt A, et al. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension. 2013;61(6):1354–9.
83. Vermeer SE, Den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM, et al. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2003;34(2):392–6.
84. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2002;33(1):21–5.
85. van Velsen EF, Vernooij MW, Vrooman HA, van der Lugt A, Breteler MM, Hofman A, et al. Brain cortical thickness in the general elderly population: the Rotterdam Scan Study. Neurosci Lett. 2013;550:189–94.
86. Bos D, Ikram MA, Elias-Smale SE, Krestin GP, Hofman A, Witteman JC, et al. Calcification in major vessel beds relates to vascular brain disease. Arterioscler Thromb Vasc Biol. 2011;31(10):2331–7.
87. Bos D, Vernooij MW, Elias-Smale SE, Verhaaren BF, Vrooman HA, Hofman A, et al. Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging. Alzheimers Dement. 2012;8(5 Suppl):S104–11.
88. Ikram MA, Vernooij MW, Vrooman HA, Hofman A, Breteler MM. Brain tissue volumes and small vessel disease in relation to the risk of mortality. Neurobiol Aging. 2009;30(3):450–6.
89. de Bruijn RF, Akoudad S, Cremers LG, Hofman A, Niessen WJ, van der Lugt A, et al. Determinants, MRI correlates, and prognosis of mild cognitive impairment: the Rotterdam Study. J Alzheimers Dis. 2014;42(Suppl 3):S239–49.
90. Ikram MA, Vrooman HA, Vernooij MW, den Heijer T, Hofman A, Niessen WJ, et al. Brain tissue volumes in relation to cognitive function and risk of dementia. Neurobiol Aging. 2010;31(3):378–86.
91. Poels MM, Steyerberg EW, Wieberdink RG, Hofman A, Koudstaal PJ, Ikram MA, et al. Assessment of cerebral small vessel disease predicts individual stroke risk. J Neurol Neurosurg Psychiatry. 2012;83(12):1174–9.
92. Verlinden VJ, van der Geest JN, de Groot M, Hofman A, Niessen WJ, van der Lugt A et al. Structural and microstructural brain changes predict impairment in daily functioning. Am J Med. 2014;127(11):1089–96 e2.
93. Poels MM, Ikram MA, Vernooij MW. Improved MR imaging detection of cerebral microbleeds more accurately identifies persons with vasculopathy. AJNR Am J Neuroradiol. 2012;33(8):1553–6.
94. Poels MM, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van der Lugt A, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke. 2010;41(10 Suppl):S103–6.
95. Poels MM, Ikram MA, van der Lugt A, Hofman A, Krestin GP, Breteler MM, et al. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke. 2011;42(3):656–61.
96. Mesker DJ, Poels MM, Ikram MA, Vernooij MW, Hofman A, Vrooman HA, et al. Lobar distribution of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol. 2011;68(5):656–9.
97. Vernooij MW, Haag MD, van der Lugt A, Hofman A, Krestin GP, Stricker BH, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol. 2009;66(6):714–20.
98. Darweesh SK, Leening MJ, Akoudad S, Loth DW, Hofman A, Ikram MA, et al. Clopidogrel use is associated with an increased prevalence of cerebral microbleeds in a stroke-free population: the Rotterdam study. J Am Heart Assoc. 2013;2(5):e000359.
99. Akoudad S, Darweesh SK, Leening MJ, Koudstaal PJ, Hofman A, van der Lugt A, et al. Use of coumarin anticoagulants and cerebral microbleeds in the general population. Stroke. 2014;45(11):3436–9.
100. Akoudad S, Ikram MA, Koudstaal PJ, Hofman A, van der Lugt A, Vernooij MW. Cerebral microbleeds and the risk of mortality in the general population. Eur J Epidemiol. 2013;28(10):815–21.
101. Akoudad S, Portegies ML, Koudstaal PJ, Hofman A, van der Lugt A, Ikram MA, et al. Cerebral microbleeds are associated with an increased risk of stroke: the Rotterdam Study. Circulation. 2015;132(6):509–16.
102. Akoudad S, de Groot M, Koudstaal PJ, van der Lugt A, Niessen WJ, Hofman A, et al. Cerebral microbleeds are related to loss of white matter structural integrity. Neurology. 2013;81(22):1930–7.
103. Akoudad S, Ikram MA, Koudstaal PJ, Hofman A, Niessen WJ, Greenberg SM, et al. Cerebral microbleeds are associated with the progression of ischemic vascular lesions. Cerebrovasc Dis. 2014;37(5):382–8.
104. Poels MM, Ikram MA, van der Lugt A, Hofman A, Niessen WJ, Krestin GP, et al. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology. 2012;78(5):326–33.
105. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Vrooman HA, Hofman A, et al. Total cerebral blood flow and total brain perfusion in the general population: the Rotterdam Scan Study. J Cereb Blood Flow Metab. 2008;28(2):412–9.
106. Zonneveld HI, Loehrer EA, Hofman A, Niessen WJ, van der Lugt A, Krestin GP, et al. The bidirectional association between reduced cerebral blood flow and brain atrophy in the general population. J Cereb Blood Flow Metab. 2015;. doi:10.1038/jcbfm.2015.157.
107. Sedaghat S, Vernooij MW, Loehrer E, Mattace-Raso FU, Hofman A, van der Lugt A, et al. Kidney function and cerebral blood flow: The Rotterdam Study. J Am Soc Nephrol. 2015;. doi:10.1681/ASN.2014111118.
108. Poels MM, Ikram MA, Vernooij MW, Krestin GP, Hofman A, Niessen WJ, et al. Total cerebral blood flow in relation to cognitive function: the Rotterdam Scan Study. J Cereb Blood Flow Metab. 2008;28(10):1652–5.
109. Loehrer E, Vernooij MW, van der Lugt A, Hofman A, Ikram MA. Migraine and cerebral blood flow in the general population. Cephalalgia. 2015;35(2):190–8.
110. de Groot M, Ikram MA, Akoudad S, Krestin GP, Hofman A, van der Lugt A, et al. Tract-specific white matter degeneration in aging: the Rotterdam Study. Alzheimers Dement. 2015;11(3):321–30.
111. de Groot M, Verhaaren BF, de Boer R, Klein S, Hofman A, van der Lugt A, et al. Changes in normal-appearing white matter precede development of white matter lesions. Stroke. 2013;44(4):1037–42.
112. Sedaghat S, Cremers LG, de Groot M, Hoorn EJ, Hofman A, van der Lugt A, et al. Kidney function and microstructural integrity of brain white matter. Neurology. 2015;85(2):154–61.
113. Ikram MA, DeCarli C. Next frontiers in the genetic epidemiology of Alzheimer’s disease. Eur J Epidemiol. 2012;27(11):831–6.
114. Ikram MA, Fornage M, Smith AV, Seshadri S, Schmidt R, Debette S, et al. Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet. 2012;44(5):539–44.
115. Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivieres S, Jahanshad N, et al. Common genetic variants influence human subcortical brain structures. Nature. 2015;520(7546):224–9.
116. Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, Aulchenko YS, et al. Genomewide association studies of stroke. N Engl J Med. 2009;360(17):1718–28.
117. Fornage M, Debette S, Bis JC, Schmidt H, Ikram MA, Dufouil C, et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol. 2011;69(6):928–39.
118. Verhaaren BF, Debette S, Bis JC, Smith JA, Ikram MK, Adams HH, et al. Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet. 2015;8(2):398–409.
119. Debette S, Bis JC, Fornage M, Schmidt H, Ikram MA, Sigurdsson S, et al. Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke. 2010;41(2):210–7.
120. Chauhan G, Adams HH, Bis JC, Weinstein G, Yu L, Toglhofer AM et al. Association of Alzheimer’s disease GWAS loci with MRI markers of brain aging. Neurobiol Aging. 2015;36(4):1765 e7-16.
121. Adams HH, Verhaaren BF, Vrooman HA, Uitterlinden AG, Hofman A, van Duijn CM, et al. TMEM106B influences volume of left-sided temporal lobe and interhemispheric structures in the general population. Biol Psychiatry. 2014;76(6):503–8.
122. de Bruijn RF, Schrijvers EM, de Groot KA, Witteman JC, Hofman A, Franco OH, et al. The association between physical activity and dementia in an elderly population: the Rotterdam Study. Eur J Epidemiol. 2013;28(3):277–83.
123. Dufouil C, Pereira E, Chene G, Glymour MM, Alperovitch A, Saubusse E, et al. Older age at retirement is associated with decreased risk of dementia. Eur J Epidemiol. 2014;29(5):353–61.
124. Feldman AL, Wirdefeldt K, Johansson AL, Gatz M, Pedersen NL. Evidence for modest familial co-aggregation between dementia and parkinsonism. Eur J Epidemiol. 2014;29(1):49–56.
125. Hoogendam YY, Hofman A, van der Geest JN, van der Lugt A, Ikram MA. Patterns of cognitive function in aging: the Rotterdam Study. Eur J Epidemiol. 2014;29(2):133–40.
126. Jacqmin-Gadda H, Alperovitch A, Montlahuc C, Commenges D, Leffondre K, Dufouil C, et al. 20-Year prevalence projections for dementia and impact of preventive policy about risk factors. Eur J Epidemiol. 2013;28(6):493–502.
127. Marioni RE, Proust-Lima C, Amieva H, Brayne C, Matthews FE, Dartigues JF, et al. Cognitive lifestyle jointly predicts longitudinal cognitive decline and mortality risk. Eur J Epidemiol. 2014;29(3):211–9.
128. Mons U, Schottker B, Muller H, Kliegel M, Brenner H. History of lifetime smoking, smoking cessation and cognitive function in the elderly population. Eur J Epidemiol. 2013;28(10):823–31.
129. Novak M, Toren K, Lappas G, Kok WG, Jern C, Wilhelmsen L, et al. Occupational status and incidences of ischemic and hemorrhagic stroke in Swedish men: a population-based 35-year prospective follow-up study. Eur J Epidemiol. 2013;28(8):697–704.
130. Palm F, Dos Santos M, Urbanek C, Greulich M, Zimmer K, Safer A, et al. Stroke seasonality associations with subtype, etiology and laboratory results in the Ludwigshafen Stroke Study (LuSSt). Eur J Epidemiol. 2013;28(5):373–81.
131. Pekmezovic T, Jovic J, Svetel M, Kostic VS. Prevalence of restless legs syndrome among adult population in a Serbian district: a community-based study. Eur J Epidemiol. 2013;28(11):927–30.
132. Skoog I. Is it dangerous or beneficial to drink coffee? Reflections on a meta-analysis on risk at birth and a population study on risk in late life. Eur J Epidemiol. 2014;29(10):665–6.
133. Virta JJ, Heikkila K, Perola M, Koskenvuo M, Raiha I, Rinne JO, et al. Midlife cardiovascular risk factors and late cognitive impairment. Eur J Epidemiol. 2013;28(5):405–16.
134. Zhang Z, Xu G, Liu D, Zhu W, Fan X, Liu X. Dietary fiber consumption and risk of stroke. Eur J Epidemiol. 2013;28(2):119–30.
135. Lind L, Elmstahl S, Bergman E, Englund M, Lindberg E, Michaelsson K, et al. EpiHealth: a large population-based cohort study for investigation of gene-lifestyle interactions in the pathogenesis of common diseases. Eur J Epidemiol. 2013;28(2):189–97.
136. Nevalainen O, Raitanen J, Ansakorpi H, Artama M, Isojarvi J, Auvinen A. Long-term mortality risk by cause of death in newly diagnosed patients with epilepsy in Finland: a nationwide register-based study. Eur J Epidemiol. 2013;28(12):981–90.
137. Illes J, Kirschen MP, Edwards E, Stanford LR, Bandettini P, Cho MK, et al. Ethics. Incidental findings in brain imaging research. Science. 2006;311(5762):783–4.
138. Gondrie MJ, Mali WP, Buckens CF, Jacobs PC, Grobbee DE, van der Graaf Y. The PROgnostic Value of unrequested Information in Diagnostic Imaging (PROVIDI) Study: rationale and design. Eur J Epidemiol. 2010;25(10):751–8.
139. German National Cohort C. The German National Cohort: aims, study design and organization. Eur J Epidemiol. 2014;29(5):371–82.
140. de Mutsert R, den Heijer M, Rabelink TJ, Smit JW, Romijn JA, Jukema JW, et al. The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection. Eur J Epidemiol. 2013;28(6):513–23.
141. White T, El Marroun H, Nijs I, Schmidt M, van der Lugt A, Wielopolki PA, et al. Pediatric population-based neuroimaging and the Generation R Study: the intersection of developmental neuroscience and epidemiology. Eur J Epidemiol. 2013;28(1):99–111.
142. Bos MJ, Koudstaal PJ, Hofman A, Ikram MA. Modifiable etiological factors and the burden of stroke from the Rotterdam study: a population-based cohort study. PLoS Med. 2014;11(4):e1001634.
143. de Bruijn RF, Bos MJ, Portegies ML, Hofman A, Franco OH, Koudstaal PJ, et al. The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study. BMC Med. 2015;. doi:10.1186/s12916-015-0377-5.
144. Jiang W, Ju C, Jiang H, Zhang D. Dairy foods intake and risk of Parkinson’s disease: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol. 2014;29(9):613–9.
145. Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A. Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece. Eur J Epidemiol. 2013;28(1):67–77.
146. Mensikova K, Kanovsky P, Kaiserova M, Mikulicova L, Vastik M, Hlustik P, et al. Prevalence of neurodegenerative parkinsonism in an isolated population in south-eastern Moravia, Czech Republic. Eur J Epidemiol. 2013;28(10):833–6.
147. Schernhammer E, Qiu J, Wermuth L, Lassen CF, Friis S, Ritz B. Gout and the risk of Parkinson’s disease in Denmark. Eur J Epidemiol. 2013;28(4):359–60.
148. Grant WB. The role of milk protein in increasing risk of Parkinson’s disease. Eur J Epidemiol. 2013;28(4):357.
149. Lai SW, Liao KF, Lin CL, Sung FC. Irritable bowel syndrome correlates with increased risk of Parkinson’s disease in Taiwan. Eur J Epidemiol. 2014;29(1):57–62.
150. Verlinden VJ, Maksimovic A, Mirza SS, Ikram MA, Kiefte-de Jong JC, Hofman A, et al. The associations of alcohol, coffee and tobacco consumption with gait in a community-dwelling population. Eur J Clin Nutr. 2015;. doi:10.1038/ejcn.2015.120.
151. Verlinden VJ, van der Geest JN, Heeringa J, Hofman A, Ikram MA. Gait shows a sex-specific pattern of associations with daily functioning in a community-dwelling population of older people. Gait Posture. 2015;41(1):119–24.
152. Verlinden VJ, van der Geest JN, Hofman A, Ikram MA. Cognition and gait show a distinct pattern of association in the general population. Alzheimers Dement. 2014;10(3):328–35.